1. HOME
2. Research Insight
3. Vaccines Market Size & Share - Global Future Growth Expectations

The vaccines market (including COVID-19 vaccines)  is projected to reach USD 94.9 Billion by 2029 from USD 78.0 Billion in 2024, at a CAGR of 4.0% during the forecast period. Similarly the vaccines market (excluding COVID-19 vaccines) is projected to reach USD 80.3 Billion by 2029 from USD 53.0 Billion in 2024, at a CAGR of 8.7% during the forecast period. Technological advancements in vaccine development, increasing government initiatives for immunization programs and expanding investments in research and development are some of the factors driving growth of vaccines market.

Market Size Introduction:

The global vaccines market size signifies the monetary value of vaccines sold worldwide over a defined period, typically a year. It encapsulates revenues generated from vaccine sales across various segments, including preventive vaccines, therapeutic vaccines, and veterinary vaccines. Understanding the market size is crucial for stakeholders as it provides insights into the overall demand for vaccines, prevalent diseases, vaccination coverage, and emerging trends shaping the industry. This information serves as a foundation for strategic decision-making, investment planning, and gauging the potential for future growth within the vaccines market.

Key Factors:

• Current Valuation
• Historical Growth
• Projected Growth
• Key Drivers
• Regional Analysis

To know about the assumptions considered for the study download the pdf brochure

Here's a breakdown of some key factors that will likely shape its future:

• Current Valuation:
  • As of the latest available data, the global vaccines market size stands at approximately 78.0 USD billion.
• Historical Growth:
  • Over the past decade, the vaccines market has witnessed steady growth, driven by factors such as increasing investments in healthcare infrastructure, rising prevalence of infectious diseases, and expanding immunization programs worldwide.
• Projected Growth:
  • Future growth expectations for the vaccines market remain optimistic, with forecasts indicating a compound annual growth rate (CAGR) of 4.0% over the forecast period 2024 to 2029.
• Key Drivers:
  • Factors driving the growth of the vaccines market include advancements in vaccine technology, growing awareness about preventive healthcare, rising demand for pediatric and geriatric vaccines, and the emergence of novel vaccines targeting infectious diseases such as COVID-19.
• Regional Analysis:
  • Geographically, North America, Europe, and Asia-Pacific are the leading markets for vaccines, with robust healthcare infrastructure, high vaccination coverage rates, and supportive government initiatives driving market growth.

Market Share Introduction:

Market share within the vaccines industry denotes the proportion of total market sales or revenue held by individual companies, vaccine types, or geographical regions. It serves as a key performance indicator, reflecting the competitive position and relative strength of market players in capturing demand and generating revenues. Analyzing market share data enables stakeholders to assess competitive dynamics, identify market leaders, understand consumer preferences, and evaluate the effectiveness of marketing and distribution strategies. Thus, understanding market share is essential for companies to refine their market strategies, optimize resource allocation, and capitalize on growth opportunities within the vaccines market.

Key Factors:

• Leading Players
• Segment-wise Analysis
• Emerging Players
• Market Share Dynamics
• Future Outlook

Here's a breakdown of some key factors that will likely shape its future:

• Leading Players:
  • Major pharmaceutical companies such as GSK plc (UK), Merck & Co Inc (US), Pfizer Inc (US), Sanofi (France), CSL (Australia), Emergent (US), Johnson and Johnson Services, Inc. (US), Astrazeneca (UK), Serum Institute of India Pvt Ltd (India), Bavarian Nordic (Denmark), Mitsubishi Tanabe Pharma Corporation (Japan), etc; command significant market share in the global vaccines market, owing to their extensive product portfolios, strong research and development capabilities, and global distribution networks.
• Segment-wise Analysis:
  • Within the vaccines market, different vaccine types hold varying market shares. For instance, preventive vaccines for diseases like influenza, hepatitis, and human papillomavirus (HPV) typically capture a substantial portion of the market share due to their widespread use in public health programs.
• Emerging Players:
  • While established pharmaceutical giants dominate a considerable share of the vaccines market, there is also a growing presence of smaller biotechnology firms and startups specializing in niche vaccine segments or innovative vaccine delivery technologies.
• Market Share Dynamics:
  • The vaccines market is characterized by intense competition, with companies vying to enhance their market share through strategies such as product differentiation, strategic partnerships, mergers and acquisitions, and geographical expansion.
• Future Outlook:
  • With the advent of new technologies, increasing investments in research and development, and evolving regulatory landscapes, the vaccines market is expected to witness dynamic shifts in market share, presenting both challenges and opportunities for existing players and new entrants alike.

Related Reports:

Vaccines Market by Technology (Conjugate, Recombinant, Live Attenuated, Toxoid, Viral Vector, mRNA), Type (Monovalent, Multivalent), Disease (Pneumococcal, Flu, HPV, Herpes Zoster, MMR, Rotavirus, RSV), Route of Administration - Global Forecast to 2029